Jiangsu Aidea Pharmaceutical Co Ltd (688488) - Total Liabilities

Latest as of June 2026: CN¥1.00 Billion CNY ≈ $146.43 Million USD

Based on the latest financial reports, Jiangsu Aidea Pharmaceutical Co Ltd (688488) has total liabilities worth CN¥1.00 Billion CNY (≈ $146.43 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688488 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Jiangsu Aidea Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Jiangsu Aidea Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 688488 asset base.

Jiangsu Aidea Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangsu Aidea Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Hyosung TNC Corp KO:298020	Korea	₩4.14 Trillion
WAM Capital Ltd AU:WAM	Australia	AU$41.32 Million
Piraeus Port Authority S.A AT:PPA	Greece	€226.60 Million
Econergy Renewable Energy Ltd TA:ECNR	Israel	ILA666.39 Million
Critical Metals Corp. Ordinary Shares NASDAQ:CRML	USA	$123.42 Million
Shandong Intco Recycling Resources Co Ltd SHG:688087	China	CN¥4.91 Billion
Shanghai AJ Group Co Ltd SHG:600643	China	CN¥11.78 Billion
Aksa Akrilik Kimya Sanayi AS IS:AKSA	Turkey	TL32.66 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Jiangsu Aidea Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 688488 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu Aidea Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)

The table below shows the annual total liabilities of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥839.37 Million ≈ $122.83 Million	+4.60%
2024-12-31	CN¥802.48 Million ≈ $117.43 Million	+29.22%
2023-12-31	CN¥621.03 Million ≈ $90.88 Million	+36.12%
2022-12-31	CN¥456.23 Million ≈ $66.76 Million	+265.52%
2021-12-31	CN¥124.82 Million ≈ $18.26 Million	+43.52%
2020-12-31	CN¥86.97 Million ≈ $12.73 Million	-61.30%
2019-12-31	CN¥224.74 Million ≈ $32.89 Million	+20.68%
2018-12-31	CN¥186.24 Million ≈ $27.25 Million	+28.31%
2017-12-31	CN¥145.14 Million ≈ $21.24 Million	+1.39%
2016-12-31	CN¥143.16 Million ≈ $20.95 Million	--

About Jiangsu Aidea Pharmaceutical Co Ltd

SHG:688488 China Biotechnology

Market Cap

$944.54 Million

CN¥6.45 Billion CNY

Market Cap Rank

#9230 Global

#2303 in China

Share Price

CN¥15.34

Change (1 day)

+0.66%

52-Week Range

CN¥11.59 - CN¥22.16

All Time High

CN¥42.39